Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines and Viral Vector Cancer Vaccines), Type (Prevent

Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Technology (Dendritic Cells Cancer Vaccines, Recombinant Cancer Vaccines, Antigen Cancer Vaccines, Whole Cell Cancer Vaccines and Viral Vector Cancer Vaccines), Type (Preventive Cancer Vaccines and Therapeutic Cancer Vaccines), Indication (Cervical Cancer, Prostate Cancer and Other Indications), End User (Pediatrics and Adults) and Geography

The global cancer vaccines market is expected to reach US$ 15,845.59 million by 2027 from US$ 4,568.82 million in 2019; it is estimated to grow at a CAGR of 17.2% from 2020 to 2027.

The growth of the cancer vaccines market is mainly attributed to the globally increasing incidence of cancer and rising number of initiatives related to cancer vaccines by global health research organizations and key companies. However, the commercial availability of a less number of cancer vaccines and higher costs of the same hinder the growth of the market.

Cancer vaccines either assist in the treatment of existing cancers or prevent the development of cancer. Vaccines that enhance body’s natural defense capability to fight the existing cancer are as therapeutic cancer vaccines, also known as cancer treatment vaccines. Several vaccines are autologous; they are prepared from samples taken from the patients and are specific to that patient. Frequent government initiatives and launches drive the market for cancer vaccines. In December 2019, Cancer Research UK and Vaccitech Oncology Limited announced a new partnership to bring a novel immunotherapeutic vaccine strategy to patients with lung cancer. The vaccine are intended to induce an attack on cancer cells. The vaccine is likely to deliver cancer-associated antigens (MAGE A3 and NY-ESO-1) to antigen-presenting cells, i.e., dendritic cells, leading to the generation of cytotoxic T-cells by the immune system to attack and destroy the cancer cells expressing the said antigens. Thus, the constant developments in cancer vaccines are expected to accelerate the market growth during the forecast period.

Based on type, the cancer vaccines market is segmented into preventive cancer vaccines and therapeutic cancer vaccines. The preventive cancer vaccines segment held a larger share of the market in 2019, and the same segment is anticipated to register the highest CAGR during the forecast period. Increasing number of cancer patients, growth in geriatric population, rising patient understanding of cancer therapies, development in the use of cancer vaccines in combination with other treatments, and government support to trigger the production are the key factors driving the growth of the market for preventive cancer vaccines. Based on technology, the market is segmented into dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, and viral vector cancer vaccines. Based on indication, the market is segmented into cervical cancer, prostate cancer, and other indications. On the basis of end user, the market is segmented into pediatrics and adults.

The World Health Organization (WHO), American Cancer Society, Globocan, Cancer Research UK, Centers for Disease Control and Prevention (CDC), and Clinical and Translational Immunology and Translational Research Institute, along with company websites, are a few of the major primary and secondary sources cited while preparing this report.

Reason to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the cancer vaccines market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the global cancer vaccines market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.


1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Cancer Vaccines Market – By Technology
1.3.2 Global Cancer Vaccines Market – By Type
1.3.3 Global Cancer Vaccines Market – By Indication
1.3.4 Global Cancer Vaccines Market – By End-User
1.3.5 Global Cancer Vaccines market – By Geography
2. Cancer Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Global Cancer Vaccines Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East and Africa (MEA) – PEST Analysis
4.2.5 South and Central America (SCAM) – PEST Analysis
4.3 Expert Opinions
5. Cancer Vaccines Market– Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Increase in Prevalence of Cancer Worldwide
5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines
5.2 Key Market Restraints
5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer
5.2.2 Higher Cost of Cancer Vaccines
5.3 Key Market Opportunities
5.3.1 Emerging Markets in Developing Countries
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact analysis
6. Cancer Vaccines Market – Global Analysis
6.1 Global Cancer Vaccines Market Revenue Forecast and Analysis
6.2 Global Cancer Vaccines Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players
7. Cancer Vaccines Market – By Technology
7.1 Overview
7.2 Cancer Vaccines Market, by Technology, 2019 and 2027 (%)
7.3 Dendritic Cells Cancer Vaccine
7.3.1 Overview
7.3.2 Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.5 Recombinant Cancer Vaccines
7.5.1 Overview
7.5.2 Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.6 Antigen Cancer Vaccines
7.6.1 Overview
7.6.2 Antigen Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.7 Whole Cell Cancer Vaccines
7.7.1 Overview
7.7.2 Whole Cell Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
7.8 Viral Vector Cancer Vaccines
7.8.1 Overview
7.8.2 Viral Vector Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8. Cancer Vaccines Market Analysis – By Type
8.1 Overview
8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
8.3 Preventive Cancer Vaccines
8.3.1 Overview
8.3.2 Preventive Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Therapeutic Cancer Vaccines
8.4.1 Overview
8.4.2 Therapeutic Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9. Cancer Vaccines Market Analysis – By Indication
9.1 Overview
9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
9.3 Cervical Cancer
9.3.1 Overview
9.3.2 Cervical Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Prostate Cancer
9.4.1 Overview
9.4.2 Prostate Cancer: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Other Indications
9.5.1 Overview
9.5.2 Other Indications: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
10. Cancer Vaccines Market Analysis – By End Use
10.1 Overview
10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
10.3 Pediatrics
10.3.1 Overview
10.3.2 Pediatrics: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
10.4 Adults
10.4.1 Overview
10.4.2 Adults: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
11. Cancer Vaccines Market Analysis And Forecasts To 2027 Geographical Analysis
11.1 North America: Cancer Vaccines Market
11.1.1 Overview
11.1.2 North America: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.3 North America: Cancer Vaccines Market, by Technology, 2018–2027 (USD Million)
11.1.4 North America: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.1.5 North America: Cancer Vaccines Market, by Indication, 2018–2027 (USD Million)
11.1.6 North America: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.1.7 North America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
11.1.8 US: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.1 US: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.8.2 US: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.1.8.3 US: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.1.8.4 US: Cancer Vaccines Market, by Technology2018–2027 (USD Million)
11.1.8.5 US: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.1.9 Canada: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.1 Canada: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.9.2 Canada: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.1.9.3 Canada: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.1.9.4 Canada: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.1.9.5 Canada: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.1.10 Mexico: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Mexico: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Mexico: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.1.10.3 Mexico: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.1.10.4 Mexico: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.1.10.5 Mexico: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.2 Europe: Cancer Vaccines Market
11.2.1 Overview
11.2.2 Europe: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.2.3 Europe: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.2.4 Europe: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.2.5 Europe: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.2.6 Europe: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.2.7 Europe: Cancer Vaccines Market, by Country, 2018 & 2027 (%)
11.2.8 Germany: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.1 Germany: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.8.2 Germany: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.2.8.3 Germany: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.2.8.4 Germany: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.2.8.5 Germany: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.2.9 UK: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.9.1 UK: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.9.2 UK: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.2.9.3 UK: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.2.9.4 UK: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.2.9.5 UK: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.2.10 France: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.10.1 France: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.10.2 France: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.2.10.3 France: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.2.10.4 France: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.2.10.5 France: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.2.11 Spain: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.11.1 Spain: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.11.2 Spain: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.2.11.3 Spain: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.2.11.4 Spain: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.2.11.5 Spain: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.2.12 Italy: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.12.1 Italy: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.2.12.2 Italy: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.2.12.3 Italy: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.2.12.4 Italy: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.2.12.5 Italy: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.3 Asia Pacific: Cancer Vaccines Market
11.3.1 Overview
11.3.2 Asia Pacific: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.3.3 Asia Pacific: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.3.4 Asia Pacific: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.3.5 Asia Pacific: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.3.6 Asia Pacific: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.3.7 Asia Pacific: Cancer Vaccines Market, by Country, 2018 & 2027 (%)
11.3.8 China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.8.1 China: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.8.2 China: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.3.8.3 China: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.3.8.4 China: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.3.8.5 China: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.3.9 Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.1 Japan: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.9.2 Japan: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.3.9.3 Japan: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.3.9.4 Japan: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.3.9.5 Japan: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.3.10 India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.10.1 India: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.10.2 India: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.3.10.3 India: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.3.10.4 India: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.3.10.5 India: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.3.11 South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.1 South Korea: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.11.2 South Korea: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.3.11.3 South Korea: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.3.11.4 South Korea: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.3.11.5 South Korea: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.3.12 Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.12.1 Australia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.3.12.2 Australia: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.3.12.3 Australia: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.3.12.4 Australia: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.3.12.5 Australia: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.4 Middle East & Africa: Cancer Vaccines Market
11.4.1 Overview
11.4.2 Middle East & Africa: Cancer Vaccines Market - Revenue and Forecast to 2027 (USD Million)
11.4.3 Middle East & Africa: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.4.4 Middle East & Africa: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.4.5 Middle East & Africa: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.4.6 Middle East & Africa: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.4.7 Middle East & Africa: Cancer Vaccines Market Share by Country – 2019 & 2027, (%)
11.4.8 Saudi Arabia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.1 Saudi Arabia: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.4.8.2 Saudi Arabia: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.4.8.3 Saudi Arabia: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.4.8.4 Saudi Arabia: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.4.8.5 Saudi Arabia: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.4.9 UAE: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.1 UAE: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.4.9.2 UAE: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.4.9.3 UAE: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.4.9.4 UAE: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.4.9.5 UAE: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.4.10 South Africa: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
11.4.10.1 South Africa: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.4.10.2 South Africa: Cancer Vaccines Market, by Type, 2018–2027 (USD Million)
11.4.10.3 South Africa: Cancer Vaccines Market, by Indication 2018–2027 (USD Million)
11.4.10.4 South Africa: Cancer Vaccines Market, by Technology 2018–2027 (USD Million)
11.4.10.5 South Africa: Cancer Vaccines Market, by End User, 2018–2027 (USD Million)
11.5 South and Central America: Cancer Vaccines Market
11.5.1 Overview
11.5.2 South and Central America: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.5.3 South and Central America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.5.4 South and Central America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
11.5.5 South and Central America Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.5.6 South and Central America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.5.7 South and Central America: Cancer Vaccines Market, by Country, 2019 & 2027 (%)
11.5.8 Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.1 Brazil: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.5.8.2 Brazil Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.5.8.3 Brazil Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
11.5.8.4 Brazil Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.5.8.5 Brazil Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
11.5.9 Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.1 Argentina: Cancer Vaccines Market – Revenue and Forecast to 2027 (USD Million)
11.5.9.2 Argentina Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
11.5.9.3 Argentina Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
11.5.9.4 Argentina Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
11.5.9.5 Argentina Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market
12.1 North America: Impact Assessment of COVID-19 Pandemic
12.2 Europe: Impact Assessment of COVID-19 Pandemic
12.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
12.4 Rest of World: Impact Assessment of COVID-19 Pandemic
13. Cancer Vaccines Market – Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.3.1 Overview
13.4 Inorganic Developments
13.4.1 Overview
14. Company Profiles
14.1 CSL Limited
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 ADURO BIOTECH INC.
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Astellas Pharma Inc.
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 Bristol-Myers Squibb Company
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 GlaxoSmithKline plc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Dendreon
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 AstraZeneca
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Merck & Co., Inc.
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 Sanofi (Sanofi Pasteur)
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
14.10 OSE Immunotherapeutics
14.10.1 Key Facts
14.10.2 Business Description
14.10.3 Products and Services
14.10.4 Financial Overview
14.10.5 SWOT Analysis
14.10.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 2. North America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 3. North America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 4. North America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 5. Estimated Number of New Cancer Cases and Deaths, US, 2020
Table 6. US Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 7. US Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 8. US Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 9. US Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 10. Canada Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 11. Canada Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 12. Canada Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 13. Canada Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 14. Mexico Incidence, Mortality and Prevalence by cancer site in 2018
Table 15. Mexico Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 16. Mexico Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 17. Mexico Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 18. Mexico Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 19. Europe Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 20. Europe Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 21. Europe Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 22. Europe Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 23. Incidence, Mortality and Prevalence by cancer site, 2018, Germany
Table 24. Germany Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 25. Germany Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 26. Germany Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 27. Germany Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 28. UK Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 29. UK Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 30. UK Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 31. UK Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 32. Incidence, Mortality and Prevalence by cancer site, 2018, France
Table 33. France Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 34. France Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 35. France Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 36. France Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 37. Incidence, Mortality and Prevalence by cancer site, 2018, Spain
Table 38. Spain Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 39. Spain Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 40. Spain Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 41. Spain Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 42. Incidence, Mortality and Prevalence by cancer site, 2018, Italy
Table 43. Italy Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 44. Italy Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 45. Italy Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 46. Italy Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 47. Asia Pacific Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 48. Asia Pacific Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 49. Asia Pacific Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 50. Asia Pacific Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 51. China Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 52. China Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 53. China Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 54. China Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 55. Japan Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 56. Japan Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 57. Japan Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 58. Japan Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 59. India Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 60. India Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 61. India Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 62. India Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 63. South Korea Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 64. South Korea Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 65. South Korea Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 66. South Korea Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 67. Incidence, Mortality and Prevalence by cancer site, Australia, 2018
Table 68. Australia Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 69. Australia Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 70. Australia Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 71. Australia Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 72. Middle East & Africa Cancer Vaccines Market, by Type– Revenue and Forecast to 2027 (USD Million)
Table 73. Middle East & Africa Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 74. Middle East & Africa Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 75. Middle East & Africa Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 76. Saudi Arabia Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 77. Saudi Arabia Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 78. Saudi Arabia Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 79. Saudi Arabia Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 80. UAE Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 81. UAE Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 82. UAE Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 83. UAE Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 84. South Africa Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 85. South Africa Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 86. South Africa Cancer Vaccines Market, by Technology– Revenue and Forecast to 2027 (USD Million)
Table 87. South Africa Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 88. South and Central America Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 89. South and Central America Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 90. South and Central America Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 91. South and Central America Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 92. Brazil Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 93. Brazil Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 94. Brazil Cancer Vaccines Market, by Technology – Revenue and Forecast to 2027 (USD Million)
Table 95. Brazil Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 96. Argentina Cancer Vaccines Market, by Type – Revenue and Forecast to 2027 (USD Million)
Table 97. Argentina Cancer Vaccines Market, by Indication – Revenue and Forecast to 2027 (USD Million)
Table 98. Argentina Cancer Vaccines Market, by Technology- Revenue and Forecast to 2027 (USD Million)
Table 99. Argentina Cancer Vaccines Market, by End User – Revenue and Forecast to 2027 (USD Million)
Table 100. Organic Developments Done By Companies
Table 101. Inorganic Developments Done By Companies
Table 102. Glossary of Terms, Cancer Vaccines Market
LIST OF FIGURES
Figure 1. Cancer Vaccines Market Segmentation
Figure 2. Cancer Vaccines Market Segmentation, By Region
Figure 3. Cancer Vaccines Market Overview
Figure 4. Recombinant Cancer Vaccines Segment Held Largest Share of Cancer Vaccines Market
Figure 5. APAC to Show Significant Growth During Forecast Period
Figure 6. Cancer Vaccines Market, by Geography (US$ Million)
Figure 7. Global Cancer Vaccines Market – Leading Country Markets (US$ Million)
Figure 8. Global Cancer Vaccines Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East and Africa (MEA) PEST Analysis
Figure 13. South and Central America (SCAM) PEST Analysis
Figure 14. Cancer Statistics, 2020
Figure 15. Cancer Vaccines Market Impact Analysis of Driver and Restraints
Figure 16. Global Cancer Vaccines Market – Revenue Forecast And Analysis – 2019- 2027
Figure 17. Market Positioning Of Key Players In Global Cancer Vaccines Market
Figure 18. Cancer Vaccines Market, by Technology, 2019 and 2027 (%)
Figure 19. Dendritic Cells Cancer Vaccines : Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 20. Recombinant Cancer Vaccines: Cancer Vaccines Market – Revenue and Forecast to 2027 (US$ Million)
Figure 21.

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook